Researchers report lower complication rates, lengths of hospital stay, costs
MONDAY, March 27, 2017 (HealthDay News) — Surgical glue is safe and cost-effective, compared to standard stapling, during laparoscopic sleeve gastrectomy, according to a study published online March 21 in the Journal of Evaluation in Clinical Practice.
Gregoire Mercier, M.D., Ph.D., from CHU de Montpellier in France, and colleagues compared clinical and economic outcomes in consecutive patients undergoing laparoscopic sleeve gastrectomy (2011 to 2012) who received standard stapling (99 patients; group 1) or surgical glue reinforcement (94 patients; group 2).
The researchers found that the duration of intervention was significantly shorter in group 2 (68 versus 82 minutes; P = 0.001). Complications were not significantly different between the groups, although leaks in group 1 were more severe. Group 2 had a reduced initial length of stay (4.8 versus 5.2 days; P = 0.01), as well as fewer six-month readmissions and shorter total length of stay (5.5 versus 6.1 days; P = .003). Initial inpatient cost was significantly reduced with surgical glue (€5,488 versus €6,152; P = 0.005), as was six-month total inpatient cost, which included readmissions (€6,006 versus €6,754; P = 0.005).
“Surgical glue might be a safe and cost-effective intervention in laparoscopic sleeve gastrectomy,” the authors write.
Copyright © 2017 HealthDay. All rights reserved.
